These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 18564010)

  • 1. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of typhoid vaccines in Asia: the DOMI experience.
    Ochiai RL; Acosta CJ; Agtini M; Bhattacharya SK; Bhutta ZA; Do CG; Dong B; Chen X; Stanton B; Kaljee L; Nyamete A; Galindo CM; von Seidlein L; DeRoeck D; Jodar L; Clemens JD
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S34-8. PubMed ID: 17582567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population impact of Vi capsular polysaccharide vaccine.
    Khan MI; Ochiai RL; Clemens JD
    Expert Rev Vaccines; 2010 May; 9(5):485-96. PubMed ID: 20450323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
    J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia.
    DeRoeck D; Clemens JD; Nyamete A; Mahoney RT
    Vaccine; 2005 Apr; 23(21):2762-74. PubMed ID: 15780724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera and typhoid vaccine. The current state of play.
    Cohen J
    Aust Fam Physician; 1997 Aug; 26(8):943-6. PubMed ID: 9267060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines on trial.
    Basu P
    Nature; 2005 Jul; 436(7050):484. PubMed ID: 16049470
    [No Abstract]   [Full Text] [Related]  

  • 10. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Vi vaccination on spatial patterns of typhoid fever in the slums of Kolkata, India.
    Ali M; Sur D; Kim DR; Kanungo S; Bhattacharya SK; Manna B; Ochiai RL; Clemens J
    Vaccine; 2011 Nov; 29(48):9051-6. PubMed ID: 21939716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Typhoid fever vaccination strategies.
    Date KA; Bentsi-Enchill A; Marks F; Fox K
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C55-61. PubMed ID: 25902360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI; Soofi SB; Ochiai RL; Habib MA; Sahito SM; Nizami SQ; Acosta CJ; Clemens JD; Bhutta ZA;
    Vaccine; 2012 Aug; 30(36):5389-95. PubMed ID: 22721899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
    Ivanoff B; Neira M
    Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimization model for reducing typhoid cases in developing countries without increasing public spending.
    Lauria DT; Maskery B; Poulos C; Whittington D
    Vaccine; 2009 Mar; 27(10):1609-21. PubMed ID: 19146902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
    Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
    J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
    [No Abstract]   [Full Text] [Related]  

  • 18. Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.
    Arya SC
    J Infect Dis; 2002 Mar; 185(6):845; author reply 845-6. PubMed ID: 11920305
    [No Abstract]   [Full Text] [Related]  

  • 19. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
    Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
    J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.